Influence of hypoxia on TRAIL-induced apoptosis in tumor cells

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 2, 2004, Pages 386-396

  Weinmann, Martin ^a   Marini, Patrizia ^a   Jendrossek, Verena ^a   Betsch, Angelika ^a   Goecke, Barbara ^a   Budach, Wilfried ^a   Belka, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Apoptosis; Bcl 2; Hypoxia; Radiotherapy; TRAIL

Indexed keywords

GENES; ONCOLOGY; RADIATION; TUMORS;

GROWTH RETARDATION;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT; HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER INHIBITION; CELL HYPOXIA; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; GENE ACTIVATION; GENE FUNCTION; GENE INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIATION RESPONSE; TUMOR CELL; TUMOR CELL LINE; TUMOR GROWTH; VECTOR CONTROL;

EID: 0942268141     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.09.052     Document Type: Conference Paper

References (32)

1. Harris A.L. Hypoxia - A key regulatory factor in tumour growth. Nature Rev Cancer. 2:2002;38-47.
2. Lynch E.M., Sampson L.E., Khalil A.A., et al. Cytotoxic effect of tumour necrosis factor-alpha on sarcoma F cells at tumour relevant oxygen tensions. Acta Oncol. 34:1995;423-427.
3. Weinmann M., Thews O., Schroeder T., et al. Expression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma Role of oxygenation status and tumour size . Br J Cancer. 86:2002;1355-1361.
4. Jendrossek V., Muller I., Eibl H., et al. Intracellular mediators of erucylphosphocholine-induced apoptosis. Oncogene. 22:2003;2621-2631.
5. Dong Z., Venkatachalam M.A., Wang J., et al. Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia HIF-1-independent mechanisms . J Biol Chem. 276:2001;18702-18709.
6. Park S.Y., Billiar T.R., Seol D.W. Hypoxia inhibition of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Biochem Biophys Res Commun. 291:2002;150-153.
7. Rudner J., Lepple-Wienhues A., Budach W., et al. Wild-type, mitochondrial and ER-restricted Bcl-2 inhibit DNA damage-induced apoptosis but do not affect death receptor-induced apoptosis. J Cell Sci. 114:2001;4161-4172.
8. Rudner J., Belka C., Marini P., et al. Radiation sensitivity and apoptosis in human lymphoma cells. Int J Radiat Biol. 77:2001;1-11.
9. Igney F.H., Krammer P.H. Death and anti-death Tumour resistance to apoptosis . Nat Rev Cancer. 2:2002;277-288.
10. Belka C., Schmid B., Marini P., et al. Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL. Oncogene. 20:2001;2190-2196.
11. Ashkenazi A., Pai R.C., Fong S., et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest. 104:1999;155-162.
12. Belka C., Rudner J., Wesselborg S., et al. Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis. Oncogene. 19:2000;1181-1190.
13. Semenza G.L. Expression of hypoxia-inducible factor 1 Mechanisms and consequences . Biochem Pharmacol. 59:2000;47-53.
14. Riva C., Chauvin C., Pison C., et al. Cellular physiology and molecular events in hypoxia-induced apoptosis. Anticancer Res. 18:1998;4729-4736.
15. Amellem O., Stokke T., Sandvik J.A., et al. Hypoxia-induced apoptosis in human cells with normal p53 status and function, without any alteration in the nuclear protein level. Exp Cell Res. 232:1997;361-370.
16. Banasiak K.J., Cronin T., Haddad G.G. Bcl-2 prolongs neuronal survival during hypoxia-induced apoptosis. Brain Res Mol Brain Res. 72:1999;214-225.
17. Chae H.J., Kim S.C., Han K.S., et al. Hypoxia induces apoptosis by caspase activation accompanying cytochrome C release from mitochondria in MC3T3E1 osteoblasts p38 MAPK is related in hypoxia-induced apoptosis . Immunopharmacol Immunotoxicol. 23:2001;133-152.
18. Amellem O., Pettersen E.O. Cell inactivation and cell cycle inhibition as induced by extreme hypoxia The possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage . Cell Prolif. 24:1991;127-141.
19. Graeber T.G., Peterson J.F., Tsai M., et al. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol. 14:1994;6264-6277.
20. Teicher B.A. Hypoxia and drug resistance. Cancer Metast Rev. 13:1994;139-168.
21. Gray L. Radiobiologic basis of oxygen as a modifying factor in radiation therapy. AJR Am J Roentgeol. 85:1961;803-815.
22. Vaupel P., Thews O., Kelleher D.K., et al. Oxygenation of human tumors The Mainz experience . Strahlenther Onkol. 174:1998;6-12.
23. Park Y.M., Anderson R.L., Spitz D.R., et al. Hypoxia and resistance to hydrogen peroxide confer resistance to tumor necrosis factor in murine L929 cells. Radiat Res. 131:1992;162-168.
24. Naldini A., Cesari S., Bocci V. Effects of hypoxia on the cytotoxicity mediated by tumor necrosis factor-alpha. Lymphokine Cytokine Res. 13:1994;233-237.
25. Wong G.H., Elwell J.H., Oberley L.W., et al. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58:1989;923-931.
26. Goossens V., De Vos K., Vercammen D., et al. Redox regulation of TNF signaling. Biofactors. 10:1999;145-156.
27. Chinnaiyan A.M., Prasad U., Shankar S., et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci USA. 97:2000;1754-1759.
28. Carmeliet P., Dor Y., Herbert J.M., et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. (erratum Nature 1998;1:395-525) Nature. 394:1998;485-490.
29. Shimizu S., Eguchi Y., Kosaka H., et al. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature. 374:1995;811-813.
30. Azhar G., Liu L., Zhang X., et al. Influence of age on hypoxia/reoxygenation-induced DNA fragmentation and bcl-2, bcl-xl, bax and fas in the rat heart and brain. Mech Aging Dev. 112:1999;5-25.
31. Scaffidi C., Fulda S., Srinivasan A., et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1998;1675-1687.
32. Nam S.Y., Amoscato A.A., Lee Y.J. Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway. Oncogene. 21:2002;337-346.